By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Lejrvej 37-41

Værløse    DK-3500  Denmark
Phone: 45-44-47-80-80 Fax: 45-44-47-24-25



Company News
Egalet Release: Company Closes Second Tranche Of $80 Million Secured Debt Financing 1/19/2017 8:12:39 AM
Egalet Release: Drug Company Receives FDA Approval For ARYMO ER (Morphine Sulfate) C-II, An Extended-Release Morphine Product Formulated With Abuse-Deterrent Properties For Treatment Of Chronic Pain 1/10/2017 5:53:18 AM
Egalet Announces Positive Top-Line Results From An Intranasal Human Abuse Potential Study Of Egalet-002 12/16/2016 10:43:37 AM
Egalet Appoints Robert Roche To Board Of Directors 12/8/2016 8:51:25 AM
Egalet Announces Issuance Of New Patent For Egalet-002 And Guardian Technology 12/6/2016 8:13:48 AM
Egalet Announces Filing Of Supplemental New Drug Application For OXAYDO To FDA 12/2/2016 6:20:55 AM
Egalet Announces OXAYDO Receives Pharmaceutical Composition Patent Protection Through 2024 11/17/2016 8:07:35 AM
Egalet Reports Third Quarter 2016 Financial Results 11/4/2016 9:06:19 AM
Egalet To Host Conference Call And Webcast To Discuss Third Quarter 2016 Financial Results On November 4, 2016 10/20/2016 9:54:00 AM
Why Egalet's FDA PDUFA Delay Is No Cause For Panic 10/18/2016 7:19:34 AM